Clinical Trial: Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational




Official Title: Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

Brief Summary: Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a severe inherited blistering skin disease caused by absence of type VII collagen. Patients with RDEB develop large, severly painful blisters and open wounds from minor trauma to their skin. In the future, we hope to start a gene transfer study on a specific group of RDEB subjects and we are screening subjects for that potential trial now.